These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12949938)

  • 1. Effect of carbohydrate moieties on the folate hydrolysis activity of the prostate specific membrane antigen.
    Ghosh A; Heston WD
    Prostate; 2003 Oct; 57(2):140-51. PubMed ID: 12949938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
    Pinto JT; Suffoletto BP; Berzin TM; Qiao CH; Lin S; Tong WP; May F; Mukherjee B; Heston WD
    Clin Cancer Res; 1996 Sep; 2(9):1445-51. PubMed ID: 9816319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.
    Heston WD
    Urology; 1997 Mar; 49(3A Suppl):104-12. PubMed ID: 9123729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid.
    Yao V; Berkman CE; Choi JK; O'Keefe DS; Bacich DJ
    Prostate; 2010 Feb; 70(3):305-16. PubMed ID: 19830782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells.
    Lapidus RG; Tiffany CW; Isaacs JT; Slusher BS
    Prostate; 2000 Dec; 45(4):350-4. PubMed ID: 11102961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).
    Mhaka A; Gady AM; Rosen DM; Lo KM; Gillies SD; Denmeade SR
    Cancer Biol Ther; 2004 Jun; 3(6):551-8. PubMed ID: 15044850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity.
    Barinka C; Sácha P; Sklenár J; Man P; Bezouska K; Slusher BS; Konvalinka J
    Protein Sci; 2004 Jun; 13(6):1627-35. PubMed ID: 15152093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase.
    Bacich DJ; Pinto JT; Tong WP; Heston WD
    Mamm Genome; 2001 Feb; 12(2):117-23. PubMed ID: 11210180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA).
    Tino WT; Huber MJ; Lake TP; Greene TG; Murphy GP; Holmes EH
    Hybridoma; 2000 Jun; 19(3):249-57. PubMed ID: 10952413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro targeted killing of prostate tumor cells by a synthetic amoebapore helix 3 peptide modified with two gamma-linked glutamate residues at the COOH terminus.
    Warren P; Li L; Song W; Holle E; Wei Y; Wagner T; Yu X
    Cancer Res; 2001 Sep; 61(18):6783-7. PubMed ID: 11559551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II.
    Halsted CH; Ling EH; Luthi-Carter R; Villanueva JA; Gardner JM; Coyle JT
    J Biol Chem; 1998 Aug; 273(32):20417-24. PubMed ID: 9685395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.
    Lupold SE; Hicke BJ; Lin Y; Coffey DS
    Cancer Res; 2002 Jul; 62(14):4029-33. PubMed ID: 12124337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide.
    Conway RE; Rojas C; Alt J; Nováková Z; Richardson SM; Rodrick TC; Fuentes JL; Richardson NH; Attalla J; Stewart S; Fahmy B; Barinka C; Ghosh M; Shapiro LH; Slusher BS
    Angiogenesis; 2016 Oct; 19(4):487-500. PubMed ID: 27387982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic-derived S-allylmercaptocysteine.
    Pinto JT; Qiao C; Xing J; Suffoletto BP; Schubert KB; Rivlin RS; Huryk RF; Bacich DJ; Heston WD
    Prostate; 2000 Dec; 45(4):304-14. PubMed ID: 11102955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene.
    O'Keefe DS; Su SL; Bacich DJ; Horiguchi Y; Luo Y; Powell CT; Zandvliet D; Russell PJ; Molloy PL; Nowak NJ; Shows TB; Mullins C; Vonder Haar RA; Fair WR; Heston WD
    Biochim Biophys Acta; 1998 Nov; 1443(1-2):113-27. PubMed ID: 9838072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity.
    Anilkumar G; Rajasekaran SA; Wang S; Hankinson O; Bander NH; Rajasekaran AK
    Cancer Res; 2003 May; 63(10):2645-8. PubMed ID: 12750292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific membrane antigen (PSMA) expression gives prostate cancer cells a growth advantage in a physiologically relevant folate environment in vitro.
    Yao V; Bacich DJ
    Prostate; 2006 Jun; 66(8):867-75. PubMed ID: 16496414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.
    Smith-Jones PM; Vallabahajosula S; Goldsmith SJ; Navarro V; Hunter CJ; Bastidas D; Bander NH
    Cancer Res; 2000 Sep; 60(18):5237-43. PubMed ID: 11016653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhancer.
    Noss KR; Wolfe SA; Grimes SR
    Gene; 2002 Feb; 285(1-2):247-56. PubMed ID: 12039052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.